Biogen (BIIB)
(Delayed Data from NSDQ)
$211.17 USD
-16.27 (-7.15%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $210.00 -1.17 (-0.55%) 5:54 PM ET
3-Hold of 5 3
C Value B Growth F Momentum C VGM
Detailed Estimates
EPS Estimates
Earnings Date | *BMO8/1/24 |
---|---|
Current Quarter | 4.00 |
EPS Last Quarter | 3.67 |
Last EPS Surprise | 6.38% |
ABR | 1.67 |
Earnings ESP
|
-1.09% |
---|---|
Current Year | 15.61 |
Next Year | 17.45 |
EPS (TTM) | 15.00 |
P/E (F1) | 14.57 |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 2.38B | 2.41B | 9.52B | 9.51B |
# of Estimates | 25 | 25 | 26 | 26 |
High Estimate | 2.45B | 2.50B | 9.73B | 10.37B |
Low Estimate | 2.32B | 2.25B | 9.35B | 8.63B |
Year ago Sales | 2.46B | 2.53B | 9.84B | 9.52B |
Year over Year Growth Est. | -3.07% | -4.95% | -3.24% | -0.03% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 4.00 | 3.98 | 15.61 | 17.45 |
# of Estimates | 26 | 25 | 27 | 27 |
Most Recent Consensus | 3.94 | 3.98 | 15.84 | 15.01 |
High Estimate | 6.04 | 4.27 | 15.93 | 20.90 |
Low Estimate | 3.46 | 3.01 | 15.10 | 13.75 |
Year ago EPS | 4.02 | 4.36 | 14.72 | 15.61 |
Year over Year Growth Est. | -0.50% | -8.72% | 6.05% | 11.82% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 2 | 0 | 1 | 2 |
Up Last 30 Days | 6 | 3 | 5 | 3 |
Up Last 60 Days | 6 | 3 | 5 | 3 |
Down Last 7 Days | 1 | 3 | 2 | 1 |
Down Last 30 Days | 3 | 5 | 3 | 5 |
Down Last 60 Days | 3 | 5 | 3 | 5 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 4.00 | 3.98 | 15.61 | 17.45 |
7 Days Ago | 3.98 | 3.99 | 15.60 | 17.44 |
30 Days Ago | 3.98 | 3.99 | 15.61 | 17.51 |
60 Days Ago | 3.97 | 3.99 | 15.59 | 17.50 |
90 Days Ago | 3.96 | 4.01 | 15.61 | 17.54 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 3.96 | 4.07 | 15.62 | 16.51 |
Zacks Consensus Estimate | 4.00 | 3.98 | 15.61 | 17.45 |
Earnings ESP | -1.09% | 2.22% | 0.06% | -5.40% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 3.67 | 2.95 | 4.36 | 4.02 | NA |
Estimate | 3.45 | 3.16 | 3.99 | 3.77 | NA |
Difference | 0.22 | -0.21 | 0.37 | 0.25 | 0.16 |
Surprise | 6.38% | -6.65% | 9.27% | 6.63% | 3.91% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more